… COVID-19 Clinical Evidence Taskforce was established to produce living recommendations
on the clinical care of people with COVID-19 in … clinical care to people with COVID-19. The …

… University of Birmingham, 23 play a useful part in complementing the work of the Taskforce.
… regularly been excluded from COVID-19 clinical trials. Faced with limited data for the specific …

… and people in palliative care with COVID-19. The aim of this article is to describe the
Taskforce recommendations for the care of pregnant and postpartum women with COVID-19. …

… We thank all members of the National COVID-19 Clinical Evidence Taskforce for their
magnificent contributions to the work described in this article, and acknowledge the Taskforce …

… The authors thank all of the members of the National COVID-19 Clinical Evidence Taskforce
for their magnificent contributions to the work described in this article. Steering committee: …

… While the taskforce developed recommendations in several areas, including … therapies for
people with COVID-19. We collected data on the first 12 months of the taskforce (April 2020–…

… COVID-19. This review summarizes the latest evidence in molecular, serology, and
biochemical testing in COVID-19 and highlights areas in urgent need of improvement and support. …

… testing in clinical trial settings prior to adoption. While we endorse clinical trials, especially …
the diverse populations most affected by COVID-19 and long COVID, we discourage off-label …

… Given the paucity of evidence in COVID-19 patients, nearly half of the Task Force was
unwilling to make a recommendation for or against extended prophylactic-dose anticoagulation in …

… Furthermore, the frequent detection of Aspergillus species or galactomannan (GM) in
airway samples from critically ill COVID-19 patients, limited evidence of histopathological …